activins has been researched along with Carcinoma, Pancreatic Ductal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Caffrey, TC; Chung, S; Eldani, M; Grandgenett, PM; Hollingsworth, MA; Kattamuri, C; Kim, SY; Luan, Y; O'Connell, KA; Shukla, SK; Singh, PK; Thompson, TB; Xu, PC; You, M; Yu, SY | 1 |
| Koniaris, LG; Liu, S; Liu, Y; Narasimhan, A; Shahda, S; Silverman, LM; Wan, J; Young, AR; Zhong, X; Zimmers, TA | 1 |
| Chang, CC; Chang, MC; Chang, YT; Chen, YI; Hsu, MF; Hu, CM; Jeng, YM; Lee, WH; Tien, YW | 1 |
| Bachy, S; Bernard, D; Bertolino, P; Chanal, M; Collin, G; Flaman, JM; Goehrig, D; Guillaumond, F; Hennino, A; Pasternack, A; Principe, M; Ritvos, O; Tomasini, R; Vasseur, S; Wu, Z; Zhao, Y; Ziverec, A | 1 |
| Bauer, J; Castellanos, K; Dawson, D; Grimaldo, S; Grippo, P; Guzman, G; Hwang, R; Jung, B; Krett, N; Mancinelli, G; McKinney, R; Torres, C | 1 |
| Ceppa, EP; Couch, ME; House, MG; Jiang, G; Jiang, Y; Koniaris, LG; Liu, J; Liu, Y; Nakeeb, A; Poirier, C; Pons, M; Sandusky, GE; Schmidt, CM; Shahda, S; Zhong, X; Zimmers, TA; Zyromski, NJ | 1 |
| Alcala, S; Azevedo, MM; Cañamero, M; Cioffi, M; Erkan, M; Garcia, E; García-Silva, S; Gomez-Lopez, G; Heeschen, C; Hermann, PC; Hidalgo, M; Kleeff, J; Miranda-Lorenzo, I; Sainz, B; Sanchez-Ripoll, Y; Sancho, P; Tatari, M | 1 |
| Aicher, A; Cioffi, M; Dorado, J; Hahn, S; Heeschen, C; Hidalgo, M; Lonardo, E; Miranda-Lorenzo, I; Ramirez, JC; Reis Vieira, C; Sainz, B; Sanchez-Ripoll, Y; Trabulo, SM | 1 |
8 other study(ies) available for activins and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling.
Topics: Activins; Adipocytes, White; Adiposity; Animals; Atrophy; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Line; Fibrosis; Humans; Inhibin-beta Subunits; Intra-Abdominal Fat; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Pancreatic Neoplasms; Signal Transduction; Uncoupling Protein 1 | 2022 |
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Topics: Activins; Adenocarcinoma; Animals; Cachexia; Carcinoma, Pancreatic Ductal; Estradiol; Female; Follistatin-Related Proteins; Humans; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Pancreatic Neoplasms; Phenotype; Sex Factors | 2022 |
Homophilic ATP1A1 binding induces activin A secretion to promote EMT of tumor cells and myofibroblast activation.
Topics: Activins; Carcinoma, Pancreatic Ductal; Cell Communication; Epithelial-Mesenchymal Transition; Humans; Myofibroblasts; Pancreatic Neoplasms; Sodium-Potassium-Exchanging ATPase | 2022 |
Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Animals; Carcinoma, Pancreatic Ductal; Cellular Senescence; Disease Progression; Genes, ras; Humans; Mice; Pancreatic Neoplasms; Phosphorylation; Precancerous Conditions; Proto-Oncogene Proteins p21(ras); Transcriptional Activation | 2020 |
Role of stromal activin A in human pancreatic cancer and metastasis in mice.
Topics: Activins; Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Epithelial Cells; Epithelium; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Pancreatic Neoplasms; Pancreatic Stellate Cells; Prognosis; Stromal Cells; Survival Analysis; Tumor Burden; Up-Regulation | 2021 |
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Topics: Activin Receptors, Type II; Activins; Animals; Biomarkers; Body Weights and Measures; Cachexia; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Management; Disease Models, Animal; Gene Expression; Humans; Immunohistochemistry; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Pancreatic Neoplasms; Prognosis; Proportional Hazards Models | 2019 |
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
Topics: Activins; Animals; Antimicrobial Cationic Peptides; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cathelicidins; Cell Self Renewal; Gene Expression; Humans; Macrophages; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplastic Stem Cells; Pancreatic Neoplasms; Protein Array Analysis; Purinergic P2X Receptor Antagonists; Receptors, Formyl Peptide; Receptors, Purinergic P2X7; Signal Transduction; Tissue Array Analysis; Transforming Growth Factor beta1; Tumor Microenvironment | 2015 |
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Topics: Activins; Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cell Cycle Checkpoints; Cell Self Renewal; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p57; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Nodal Protein; Pancreatic Neoplasms; RNA, Long Noncoding; Signal Transduction; T-Box Domain Proteins; Transcriptome; Transforming Growth Factor beta1 | 2015 |